Dual inhibition of PI3K and mTOR by VS-5584 suppresses thrombus formation.

about

Dual inhibition of PI3K and mTOR by VS-5584 suppresses thrombus formation.

Item

http://www.wikidata.org/entity/Q50647961

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Dual inhibition of PI3K and mTOR by VS-5584 suppresses thrombus formation.

@en

Dual inhibition of PI3K and mTOR by VS-5584 suppresses thrombus formation.

@nl

type

Item

label

Dual inhibition of PI3K and mTOR by VS-5584 suppresses thrombus formation.

@en

Dual inhibition of PI3K and mTOR by VS-5584 suppresses thrombus formation.

@nl

prefLabel

Dual inhibition of PI3K and mTOR by VS-5584 suppresses thrombus formation.

@en

Dual inhibition of PI3K and mTOR by VS-5584 suppresses thrombus formation.

@nl

P1476

Dual inhibition of PI3K and mTOR by VS-5584 suppresses thrombus formation.

@en

P2093

Emmanuel Ampofo

http://www.w3.org/2001/XMLSchema#string

Hermann Eichler

http://www.w3.org/2001/XMLSchema#string

Isabelle Müller

http://www.w3.org/2001/XMLSchema#string

Matthias W Laschke

http://www.w3.org/2001/XMLSchema#string

Michael D Menger

http://www.w3.org/2001/XMLSchema#string

Thomas Später

http://www.w3.org/2001/XMLSchema#string

P2860

mTOR signaling in growth control and disease

Nuclear translocation of p65 NF-kappaB is sufficient for VCAM-1, but not ICAM-1, expression in TNF-stimulated smooth muscle cells: Differential requirement for PARP-1 expression and interaction

PI3K-PKB/Akt pathway

Flow cytometric measurement of platelet-leukocyte aggregates: a possible target to monitor platelet function?

An innovative strategy for dual inhibitor design and its application in dual inhibition of human thymidylate synthase and dihydrofolate reductase enzymes

BAY 43-9006 exhibits broad spectrum oral antitumor activity and targets the RAF/MEK/ERK pathway and receptor tyrosine kinases involved in tumor progression and angiogenesis

Vascular endothelial growth factor expression of intercellular adhesion molecule 1 (ICAM-1), vascular cell adhesion molecule 1 (VCAM-1), and E-selectin through nuclear factor-kappa B activation in endothelial cells.

Modulation of platelet activation and thrombus formation using a pan-PI3K inhibitor S14161.

mTOR inhibitors in cancer therapy.

The roles and mechanisms of PAR4 and P2Y12/phosphatidylinositol 3-kinase pathway in maintaining thrombin-induced platelet aggregation

P304

1-11

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/09537104.2017.1306040

http://www.w3.org/2001/XMLSchema#string

P577

2017-05-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28503993

http://www.w3.org/2001/XMLSchema#string